DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-80,490

NOVARTIS PHARMACEUTICALS CORPORATION
PRIMARY CARE BUSINESS UNIT (SALES) DIVISION
EAST OPERATING UNIT, NORTH OPERATING UNIT AND
SOUTH OPERATING UNIT
FORMERLY KNOWN AS SOUTHEAST OPERATING UNIT, SOUTHWEST OPERATING
UNIT, NORTHWEST OPERATING UNIT AND
NORTHEAST OPERATING UNIT
INCLUDING ON-SITE LEASED WORKERS FROM INVENTIV HEALTH, ASHFIELD
HEALTHCARE, AND PRO UNLIMITED
EAST HANOVER, NEW JERSEY
AND
OFF-SITE WORKERS OF NOVARTIS PHARMACEUTICALS CORPORATION, PRIMARY
CARE BUSINESS UNIT (SALES) DIVISION, EAST OPERATING UNIT IN
ILLINOIS WHO REPORT TO
EAST HANOVER, NEW JERSEY


Amended Certification Regarding Eligibility to
Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended (“Act”), 19 U.S.C. § 2273, the Department of Labor issued
a Certification of Eligibility to Apply for Worker Adjustment
Assistance on January 6, 2012, applicable to workers of Novartis
Pharmaceuticals Corporation, Primary Care Business Unit (Sales)
Division, East Hanover, New Jersey. The Department’s notice of
determination was published in the Federal Register on January
24, 2012 (77 FR 3501). The notice was amended on May 4, 2012 and
October 17, 2012 to include workers under the control of the
subject firm working off-site in Illinois and to include the
primary Care Business Unit Division that is part of the East
Operating Unit. The amended notices were published in the
Federal Register on May 16, 2012 (77 FR 28901) and October 29,
2012 (77 FR 65581) respectively.
At the request of a company official, the Department
reviewed the certification for workers of the subject firm.
New information shows that following a company merger, the
East Operating Unit, North Operating Unit and South Operating
Unit, formerly known as Southeast Operating Unit, Southwest
Operating Unit, Northwest Operating Unit and Northeast Operating
Unit of the Primary Care Business Unit (Sales) Division of the
subject firm operate in the same capacity, together are part of a
continuous operation and all experienced worker separations due
to increased aggregate imports of pharmaceuticals.
The intent of the Department’s certification is to include
all workers of the subject firm who were adversely affected by
increased aggregate imports. The amended notice applicable to TA-
W-80,490 is hereby issued as follows:







“All workers of Novartis Pharmaceuticals Corporation,
Primary Care Business Unit (Sales) Division, East Operating
Unit, North Operating Unit and South Operating Unit,
formerly known as Southeast Operating Unit, Southwest
operating Unit, Northwest Operating Unit and Northeast
Operating Unit, including on-site leased workers from
Inventiv Health, Ashfield Healthcare, and Pro Unlimited,
East Hanover, New Jersey, and off-site workers of Novartis
Pharmaceuticals Corporation, Primary Care Business Unit
(Sales) Division, East Operating Unit in Illinois who report
to East Hanover, New Jersey, who became totally or partially
separated from employment on or after October 3, 2010,
through January 6, 2014, and all workers in the group
threatened with total or partial separation from employment
on the date of certification through two years from the date
of certification, are eligible to apply for adjustment
assistance under Chapter 2 of Title II of the Trade Act of
1974, as amended.”
Signed in Washington, D.C., this 19th day of December, 2012

/s/ Del Min Amy Chen
______________________________
DEL MIN AMY CHEN
Certifying Officer, Office of
Trade Adjustment Assistance

4510-FN-P


DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-80,490

NOVARTIS PHARMACEUTICALS CORPORATION
PRIMARY CARE BUSINESS UNIT (SALES) DIVISION
INCLUDING ON-SITE LEASED WORKERS FROM INVENTIV HEALTH, ASHFIELD
HEALTHCARE, AND PRO UNLIMITED
EAST HANOVER, NEW JERSEY

Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended (“Act”), 19 U.S.C. § 2273, the Department of Labor herein
presents the results of an investigation regarding certification
of eligibility to apply for worker adjustment assistance.
The group eligibility requirements for workers of a firm
under Section 222(a) of the Act, 19 U.S.C. § 2272(a), are
satisfied if the following criteria are met:
(1) a significant number or proportion of the workers in such
workers’ firm have become totally or partially separated, or
are threatened to become totally or partially separated; and

(2)(A)(i) the sales or production, or both, of such firm have
decreased absolutely; and

(ii)(I) imports of articles or services like or directly
competitive with articles produced or services supplied by
such firm have increased; and

(iii) the increase in imports described in clause (ii)
contributed importantly to such workers’ separation or
threat of separation and to the decline in the sales or
production of such firm.

The investigation was initiated in response to a petition
filed on October 4, 2011 by a state workforce office on behalf of
workers of Novartis Pharmaceuticals Corporation, Primary Care
Business Unit (Sales) Division, East Hanover, New Jersey. The
workers’ firm is engaged in activities related to the production
of pharmaceuticals. The worker group is engaged in the supply of
sales for pharmaceuticals. The subject worker group includes on-
site leased workers from InVentiv Health, Ashfield Healthcare,
and Pro Unlimited.
During the course of the investigation, information was
collected from the workers’ firm and the U.S. Census Bureau
Current Industrial Report.
Section 222(a)(1) has been met because a significant number
or proportion of the workers in such workers’ firm have become
totally or partially separated, or are threatened to become
totally or partially separated.
Section 222(a)(2)(A)(i) has been met because the sales and
production of pharmaceuticals by Novartis Pharmaceuticals
Corporation have decreased.
Section 222(a)(2)(A)(ii) has been met because aggregate
imports of articles like or directly competitive with the
pharmaceuticals by Novartis Pharmaceuticals Corporation have
increased.
Finally, Section 222(a)(2)(A)(iii) has been met because
increased aggregate imports contributed importantly to the worker
group separations and sales/production declines at Novartis
Pharmaceuticals Corporation.
Conclusion
After careful review of the facts obtained in the
investigation, I determine that workers of Novartis
Pharmaceuticals Corporation, Primary Care Business Unit (Sales)
Division, including on-site leased workers from InVentiv Health,
Ashfield Healthcare, and Pro Unlimited, East Hanover, New Jersey,
who are engaged in activities related to sales of pharmaceuticals
meet the worker group certification criteria under Section 222(a)
of the Act, 19 U.S.C. § 2272(a). In accordance with Section 223
of the Act, 19 U.S.C. § 2273, I make the following certification:


“All workers of Novartis Pharmaceuticals Corporation,
Primary Care Business Unit (Sales) Division, including on-
site leased workers from InVentiv Health, Ashfield
Healthcare, and Pro Unlimited, East Hanover, New Jersey, who
became totally or partially separated from employment on or
after October 3, 2010, through two years from the date of
certification, and all workers in the group threatened with
total or partial separation from employment on the date of
certification through two years from the date of
certification, are eligible to apply for adjustment
assistance under Chapter 2 of Title II of the Trade Act of
1974, as amended.”
Signed in Washington, D.C. this 6th day of January, 2012

/s/ Michael W, Jaffe
______________________________
MICHAEL W. JAFFE
Certifying Officer, Office of
Trade Adjustment Assistance





3